In this article, Freis discussed his two years of clinical work with hexamethonium, a ganglion-blocking drug. Though it was a potent antihypertensive agent, it was difficult to find and maintain an effective dose, and there were serious side-effects, as this article shows.
Copyright:
The National Library of Medicine believes this item to be in the public domain. (More information)
